Visceral obesity and the role of the somatotropic axis in the development of metabolic complications (Q34349513)

1 August 2017

1 reference

title

Visceral obesity and the role of the somatotropic axis in the development of metabolic complications (English)

1 reference

1 August 2017

0 references

Franco C

1

1 reference

PubMed ID

11527097

1 August 2017

Bengtsson BA

series ordinal

2

1 reference

PubMed ID

11527097

1 August 2017

Johannsson G

series ordinal

3

1 reference

1 August 2017

1 June 2001

1 reference

Growth Hormone & I G F Research

1 August 2017

1 reference

1 August 2017

11 Suppl A

1 reference

1 August 2017

S97-102

1 reference

High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Visceral obesity: a "civilization syndrome".

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Basic and clinical aspects of regional fat distribution

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

The development of cardiovascular disease in relation to anthropometric indices and hypertension in British adults

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Blood pressure in relation to obesity, insulin and the hypothalamic-pituitary-adrenal axis in Swedish men.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Waist circumference as a measure for indicating need for weight management.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Abdominal adiposity and coronary heart disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Sagittal abdominal diameter compared with other anthropometric measurements in relation to cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Effects of growth hormone treatment on visceral adipose tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Relationship between volumes and areas from single transverse scans of intra-abdominal fat measured by magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Insulin resistance and obesity. The role of fat distribution pattern

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Relation of body fat distribution to metabolic complications of obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Regional adiposity and morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

From obesity to diabetes: why, when and who?

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Metabolic complications of obesity. Pathophysiologic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

The hormone resistin links obesity to diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Neuroendocrine abnormalities in human obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Activation of the hypothalamic-pituitary-adrenal axis in obesity: cause or consequence?

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Androgens and abdominal obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Perturbations of the hypothalamic-pituitary-adrenal axis and the metabolic syndrome in ageing

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Hypertension and the metabolic syndrome: closely related central origin?

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Androgen treatment of abdominally obese men.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

The importance of diagnosing the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Neurophysiological regulation and target-tissue impact of the pulsatile mode of growth hormone secretion in the human

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

GH-binding protein in obese men with varying glucose tolerance: relationship to body fat distribution, insulin secretion and the GH-IGF-I axis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Growth hormone and ageing

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

A receptor in pituitary and hypothalamus that functions in growth hormone release

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Growth hormone secretagogue increases muscle strength during remobilization after canine hindlimb immobilization

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Intranasal administration of the GHRP hexarelin accelerates growth in short children

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

Sick leave and disability pension before and after treatment for obesity: a report from the Swedish Obese Subjects (SOS) study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980016-2

7 January 2021

10.1016/S1096-6374(01)80016-2

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11527097